These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32575521)

  • 41. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
    Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
    J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
    Guo L; LaDu MJ; Van Eldik LJ
    J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O; Dolev I; Belinson H; Michaelson DM
    J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid-β.
    Ghosh S; Sil TB; Dolai S; Garai K
    FEBS J; 2019 Dec; 286(23):4737-4753. PubMed ID: 31287614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
    Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
    J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of domain interaction on apolipoprotein E levels in mouse brain.
    Ramaswamy G; Xu Q; Huang Y; Weisgraber KH
    J Neurosci; 2005 Nov; 25(46):10658-63. PubMed ID: 16291938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology.
    Carare RO; Bernardes-Silva M; Newman TA; Page AM; Nicoll JA; Perry VH; Weller RO
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):131-44. PubMed ID: 18208483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
    Ezra Y; Oron L; Moskovich L; Roses AD; Beni SM; Shohami E; Michaelson DM
    Neuroscience; 2003; 121(2):315-25. PubMed ID: 14521991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease.
    Evans KC; Berger EP; Cho CG; Weisgraber KH; Lansbury PT
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):763-7. PubMed ID: 7846048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
    Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
    Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
    Rapp A; Gmeiner B; Hüttinger M
    Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
    Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
    J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.
    Boehm-Cagan A; Bar R; Harats D; Shaish A; Levkovitz H; Bielicki JK; Johansson JO; Michaelson DM
    PLoS One; 2016; 11(11):e0166195. PubMed ID: 27824936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes.
    Blanchard JW; Bula M; Davila-Velderrain J; Akay LA; Zhu L; Frank A; Victor MB; Bonner JM; Mathys H; Lin YT; Ko T; Bennett DA; Cam HP; Kellis M; Tsai LH
    Nat Med; 2020 Jun; 26(6):952-963. PubMed ID: 32514169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment.
    Salomon-Zimri S; Glat MJ; Barhum Y; Luz I; Boehm-Cagan A; Liraz O; Ben-Zur T; Offen D; Michaelson DM
    J Alzheimers Dis; 2016 Jun; 53(4):1443-58. PubMed ID: 27372644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Silico Analysis of the Antagonist Effect of Enoxaparin on the ApoE4-Amyloid-Beta (A
    Aguilar-Pineda JA; Paco-Coralla SG; Febres-Molina C; Gamero-Begazo PL; Shrivastava P; Vera-López KJ; Davila-Del-Carpio G; López-C P; Gómez B; Lino Cardenas CL
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia.
    MacGregor Sharp M; Saito S; Keable A; Gatherer M; Aldea R; Agarwal N; Simpson JE; Wharton SB; Weller RO; Carare RO
    Acta Neuropathol Commun; 2020 Aug; 8(1):131. PubMed ID: 32771063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.